Takeda Pharmaceutical TAK
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 14.64 | 68,996,000 | -11,802 | |||
| 2025Q2 | 15.46 | 39.12 | 184,565,000 | 124,243 | ||
| 2025Q1 | 14.87 | 68,543,000 | -103,155 | |||
| 2024Q4 | 13.24 | -22,448,000 | 23,789 | |||
| 2024Q3 | 14.22 | 273,638,000 | 92,046 | |||
| 2024Q2 | 12.94 | 29.97 | 166,328,000 | 95,248 | ||
| 2024Q1 | 13.89 | 96,810,000 | -3,018 | |||
| 2023Q4 | 14.27 | 54,668,000 | 105,720 | |||
| 2023Q3 | 15.47 | -15.34 | -49,342,000 | -48,030 | ||
| 2023Q2 | 15.71 | 28.56 | 168,571,000 | 89,395 | ||
| 2023Q1 | 16.48 | 9.65 | 151,164,000 | 31,134 | ||
| 2022Q4 | 15.60 | 37.93 | 146,990,000 | 119,127 | ||
| 2022Q3 | 12.97 | 19.74 | 104,437,000 | 61,742 | ||
| 2022Q2 | 14.04 | 33.78 | 150,516,000 | 105,014 | ||
| 2022Q1 | 14.32 | -1,618,000 | -11,358 | |||
| 2021Q4 | 13.63 | 18.34 | 116,484,000 | 57,769 | ||
| 2021Q3 | 16.38 | 14.54 | 97,427,000 | 45,964 | ||
| 2021Q2 | 16.83 | 43.73 | 248,552,000 | 137,684 | ||
| 2021Q1 | 18.26 | -20,418,000 | 197,098 | |||
| 2020Q4 | 18.20 | 29.31 | 143,141,000 | 92,359 |